Biontech

EU watchdog approves vaccine targeting new Omicron sub-variants

The "bivalent" jab, made by Pfizer/BioNTech, is directed at the highly infectious BA.4 and BA.5 types of the variant.

EU's drug regulator gives nod to first Omicron variant jabs

The European Medicines Agency has approved jabs targeting both the original virus and the BA.1 subvariant of Omicron ahead of a feared Covid surge in the latter part of this year.

Moderna sues Pfizer, BioNTech over Covid vaccine technology

Moderna says Pfizer and BioNTech’s vaccine Comirnaty infringes on patents Moderna filed several years ago protecting the technology behind its preventive shot, Spikevax.

BioNTech, Pfizer to start testing next-generation vaccine for coronaviruses

The two partners, makers of the Western world's most widely used Covid-19 shot, are currently discussing with regulators enhanced versions of their established shot to better protect against the Omicron variant and its sublineages.

EU regulator approves AstraZeneca Covid jab as booster

The vaccine can now be used as a booster following the two-dose Vaxzevria schedule or by those who have been vaccinated by an mRNA vaccine, such as the ones by Pfizer and BioNTech or Moderna.

Fourth Pfizer dose shields elderly from Covid but protection ‘short-lived’

A study on 1.3 million people aged 60 and older looked at data from the Israeli Ministry of Health database between January 10 and March 2, when the Omicron variant was predominant.

Study: Pfizer-BioNTech shots less effective in ages 5-11 – latest updates

Covid-19 has infected more than 435M people and killed over 5.96M worldwide. Here are some of the latest coronavirus-related developments:

BioNTech CEO: World better prepared for Covid variants – latest updates

Covid-19 has infected more than 418M people and killed over 5.8M worldwide. Here are some of the latest coronavirus-related developments:

Omicron infections slowing where variant first hit – latest updates

Covid-19 has infected more than 382M people and killed over 5.7M worldwide. Here are some of the latest coronavirus-related developments:

Pfizer vaccine 'partially protective' against Omicron

The Omicron variant can partially evade the protection from Pfizer and BioNTech's coronavirus vaccine, according to research.

Vaccine likely to protect against severe Covid from Omicron: BioNTech CEO

BioNTech's Chief Executive Ugur Sahin says the established vaccine will likely prevent hospitalisation from the new Omicron virus variant and there is no reason to be particularly worried.

World on alert as highly contagious Omicron variant continues to spread

New cases were confirmed in Australia, Germany, UK and Italy, while Israel closes its borders to all foreigners in a bid to stem the spread of the new Omicron variant of the coronavirus.